Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

SHA:688180 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,006	2,502	3,788	5,997	3,507	3,385
Short-Term Investments	-	-	-	17.93	-	-
Trading Asset Securities	501.2	430.51	-	-	-	0.02
Cash & Short-Term Investments	3,507	2,933	3,788	6,015	3,507	3,385
Cash Growth	5.90%	-22.58%	-37.02%	71.53%	3.59%	177.26%
Accounts Receivable	526.35	509.82	483.23	232.73	1,301	664.44
Other Receivables	1.98	36.44	374.01	78.81	28.05	22.84
Receivables	528.33	546.26	857.23	314.25	1,329	687.28
Inventory	556.9	584.47	538.05	599.02	484.6	343.43
Prepaid Expenses	-	-	-	239.82	-	-
Other Current Assets	192.44	220.38	387.59	36.94	524.79	283
Total Current Assets	4,785	4,284	5,571	7,205	5,845	4,699
Property, Plant & Equipment	4,263	4,195	3,809	3,278	2,801	2,377
Long-Term Investments	307.35	1,226	1,133	1,292	1,485	422.9
Other Intangible Assets	500.52	521.41	546.96	98.91	264.98	162.09
Long-Term Deferred Tax Assets	88.92	87.05	103.4	228.43	88.55	26.11
Long-Term Deferred Charges	11.52	6.12	12.6	-	27.79	13.24
Other Long-Term Assets	1,720	461.94	167.14	473.39	522.34	297.73
Total Assets	11,676	10,782	11,343	12,576	11,035	7,997
Accounts Payable	1,033	115.9	125.19	370.23	63.17	55.69
Accrued Expenses	220.78	901.44	1,046	917.21	1,603	826.28
Short-Term Debt	937.74	678.11	452.44	391.75	-	21.23
Current Portion of Long-Term Debt	-	216.5	86.96	-	10.6	231.11
Current Portion of Leases	-	30.29	35.93	43.66	34.47	25.22
Current Income Taxes Payable	-	12.41	17.98	-	63.08	-
Current Unearned Revenue	18.61	8.17	146.3	0.44	45.8	43.14
Other Current Liabilities	758.39	531.11	527.92	50.96	181.59	269.79
Total Current Liabilities	2,969	2,494	2,438	1,774	2,001	1,472
Long-Term Debt	1,780	1,980	1,196	839.58	490	542.22
Long-Term Leases	67.09	26.31	17.45	46.59	93.13	30.99
Long-Term Unearned Revenue	168.21	181.91	183.46	121.62	122.46	122.65
Other Long-Term Liabilities	299.07	168	187.15	-	11.5	1.28
Total Liabilities	5,283	4,850	4,022	2,782	2,719	2,170
Common Stock	1,027	985.69	985.69	982.87	910.76	872.5
Additional Paid-In Capital	16,306	15,407	15,395	-	11,423	8,632
Retained Earnings	-10,754	-10,341	-9,060	-	-4,389	-3,668
Treasury Stock	-30.89	-30.89	-26.89	-	-	-
Comprehensive Income & Other	-175.85	-159.94	-142.07	8,519	0.21	-9.39
Total Common Equity	6,372	5,860	7,151	9,501	7,945	5,828
Minority Interest	19.78	71.71	169.39	292.83	371.28	-0
Shareholders' Equity	6,392	5,932	7,321	9,794	8,316	5,828
Total Liabilities & Equity	11,676	10,782	11,343	12,576	11,035	7,997
Total Debt	2,785	2,931	1,789	1,322	628.19	850.78
Net Cash (Debt)	721.9	1.82	2,000	4,693	2,878	2,534
Net Cash Growth	-2.75%	-99.91%	-57.39%	63.05%	13.58%	608.08%
Net Cash Per Share	0.74	0.00	2.03	5.12	3.23	3.08
Filing Date Shares Outstanding	986.57	984.87	985.01	982.87	910.76	872.5
Total Common Shares Outstanding	986.57	984.87	985.01	982.87	910.76	872.5
Working Capital	1,816	1,790	3,133	5,431	3,843	3,226
Book Value Per Share	6.46	5.95	7.26	9.67	8.72	6.68
Tangible Book Value	5,872	5,339	6,604	9,403	7,680	5,666
Tangible Book Value Per Share	5.95	5.42	6.70	9.57	8.43	6.49
Buildings	-	1,379	1,419	-	891.83	880.3
Machinery	-	2,022	1,921	1,522	1,419	1,247
Construction In Progress	-	1,859	1,325	1,048	801.93	415.55
Leasehold Improvements	-	-	-	65.57	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.